Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Jie Qiao is a reproductive physician and biologist who is President and Chief Physician of Peking University Third Hospital. She is also Director of the National Clinical Research Center on Obstetrics & Gynecology and a member of the Chinese Academy of Engineering. Additionally, Professor Qiao is President of China Women Doctors Association and Chair for the Reproductive Medical Society of Chinese Medical Doctor Association.
Serena Nik-Zainal is a CRUK Advanced Clinician Scientist and Honorary Consultant in Clinical Genetics. Her clinical work involves rare genetic disorders, and her research focuses on cancer genomics at the University of Cambridge, UK.
As the clinical potential of RNA therapeutics begins to be unveiled, expanding the range of tissue types that can be targeted for delivery of these drugs is now the main hurdle to overcome.
Eliezer Van Allen is an assistant professor at Harvard Medical School, medical oncologist at Dana-Farber Cancer Institute and associate member of the Broad Institute of MIT and Harvard.
Siddhartha Jaiswal is an assistant professor at Stanford University School of Medicine, where he is also a member of the Immunology Program and the Institute for Stem Cell Biology and Regenerative Medicine.
‘Precision’ in a health context is usually thought to apply to the individual and seems conceptually at odds with efforts in public health directed toward improving population-level health metrics. But are these two aims truly irreconcilable?
Kristen Hege is corporate vice president of translational medicine at Celgene and a clinical professor at University of California, San Francisco (UCSF). She serves on the board of the Society for Immunotherapy of Cancer and was recognized by FierceBiotech as one of the top women in biopharma.
Emerging virtual reality systems offer intriguing therapeutic possibilities, but their development and use should be guided by ethical priorities that account for the specific vulnerabilities of patients.